The latest research study “Pneumonia Testing Market Size: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global pneumonia testing market size reached a value of US$ XX Million in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027.
Industry Overview and Application :
Pneumonia is a lower respiratory tract infection induced by viruses, bacteria, and fungi. It spreads when one inhales the airborne droplets from the cough or sneeze of an infected person. Pneumonia causes shortness of breath, inflammation in the air sacs of the lungs, mild fever, headaches, dry cough, fatigue, chills, chest pain, etc., and reduces appetite. It can be diagnosed only through a detailed physical examination, such as chest X-ray, medical history review, pulse oximetry, blood and sputum culture, bronchoscopy, fluid sample, etc. Consequently, pneumonia testing is widely adopted in hospitals, diagnostic laboratories, and other healthcare facilities across the globe.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pneumonia-testing-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Pneumonia Testing Market Trends and Drivers:
The rising usage of Point of Care (PoC) Testing and the increasing adoption of Enzyme-Linked Immunosorbent Assay (ELISA) are primarily driving the pneumonia testing market. Additionally, the development of pneumococcal urinary antigen (UAT), immunochromatographic, and advanced nucleic acid detection is also catalyzing the market growth.
Moreover, the expanding geriatric population and the inflating awareness among individuals towards the advantages of early diagnosis of the infection are acting as significant growth-inducing factors.
Besides this, the escalating number of new diagnostic product launches by the key players is anticipated to augment the pneumonia testing market over the forecasted period.
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5176&flag=F
|Pneumonia Testing Market Report Scope|
|Base year for estimation||2021|
Global Pneumonia Testing Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
The report has segmented the market on the basis of region, type, method, technology and end user.
Breakup by Type:
Breakup by Method:
• Molecular Diagnostics
• Point of Care Testing
Breakup by Technology:
• Enzyme-linked Immunosorbent Assay
• Western Blot
• Polymerase Chain Reaction
Breakup by End User:
• Diagnostic Laboratories
Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pneumonia-testing-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.